Can Fite Biofarma CANF reported its Q4 earnings results on Thursday, March 28, 2024 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Can Fite Biofarma beat estimated earnings by 96.0%, reporting an EPS of $-0.01 versus an estimate of $-0.26.
Revenue was down $42 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 4.0% increase in the share price the next day.
To track all earnings releases for Can Fite Biofarma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.